Analysis from the Centers for Disease Control and Prevention says U.S. trans fat intake dropped 58% between 2000 and 2009.
Consumption of trans fats decreased by 58% between 2000 and 2009, according to a new population analysis conducted by the U.S. Centers for Disease Control and Prevention (CDC). The news has been picked up by a host of major news sites, including NPR and Reuters.
Trans fats have developed a negative image in recent years as research grows on their potential to increase LDL cholesterol while also decreasing HDL cholesterol, or “good” cholesterol. FDA has mandated the listing of trans fats on food labels since 2003, opening up marketing opportunities for claims such as “zero trans fats.”
Published in the Journal of the American Medical Association (JAMA), the study used a subset of white adults from the National Health and Nutrition Examinatio Survey (NHANES) in 2000 and 2009. The nutrient intake data collected under NHANES, including that of trans fat consumption, is believed to provide a well-powered representation of the national population.
“The 58 percent decline shows substantial progress that should help lower the risk of cardiovascular disease in adults,” said Christopher Portier, PhD, director of CDC′s National Center for Environmental Health. “Findings from the CDC study demonstrate the effectiveness of these efforts in reducing blood [trans fatty acids] and highlight that further reductions in the levels of trans fats must remain an important public health goal.”
The CDC says future studies will focus on trans fat consumption rates in other ethnic groups.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.